Nokia and Honor Sign 5G Patent License Agreement
六月清晨搅
发表于 2024-1-4 18:14:26
283
0
0
According to a statement on Nokia's official website, Nokia announced on January 4th that it has signed a new patent cross licensing agreement with Honor, covering both parties' basic inventions in 5G and other cellular technology fields. The terms of the agreement are kept confidential between both parties. The statement stated that this is the fourth important smartphone agreement signed by Nokia in the past 12 months.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Amazon accuses Nokia of infringing on cloud technology patents
- Suddenly appearing at Apple's press conference, 'King of Glory: World' will be released next year
- AstraZeneca and Sinopharm Group reach nearly $2 billion cardiovascular drug authorization agreement
- Honor collaborates with China Mobile and JD.com to announce strategic partnership
- Qualcomm releases Snapdragon 8 Ultimate Edition: adopting the new Oryon CPU architecture, Xiaomi and Honor are the first to adopt it
- Zhihu and Tencent renew framework agreement
- Beike terminates its agreement to acquire equity in Space Intelligence
- Kaken signs Stat6 global licensing agreement with Johnson&Johnson
- Some tariff rates and items for certain goods in our country will be adjusted; Up to 100 million yuan, Liu Qiangdong increased his holdings; Honor will launch its IPO in a timely manner; Putin apologizes for the Afghan Airlines crash; Singapore oil
- Jianxun Daily | Hengrui Pharmaceutical and IDEAYA signed an authorization agreement; Liu Zhongliang, the actual controller of Weikang Pharmaceutical, has been registered